FCEL - Good current article on Fuel Cell market growth potential:
http://www.sustainablebusiness.com/index.cfm/go/news.display/id/21111
FuelCell Energy projects at California Universities:
http://www.sustainablebusiness.com/index.cfm/go/news.display/id/20108

YRCW - Big news! Runner for Monday. Tentative deal with teamsters:
http://finance.yahoo.com/news/YRC-Worldwide-Announces-prnews-2361481223.html?x=0&.v=1

FCEL - Very encouraging AF. I agree with Sean, one of the best looking charts I have seen in a while! Up a little after hours now. 1.17 x 1.18. Holding for 2.20 with ya.

FCEL - Well we got the 2.5mil share volume AF. Next week we will get the 1.21+

FCEL - With you guys. Adding to my position.

FCEL (1.19) news not announced yet. Senate Appropriations bill gives FCEL $3M

Torrington (Fuel Cell Energy)

$3 million to assist in the design and construction, and initial performance characterization of a 100 KW class fuel stack needed for the Navy’s standard military power generator applications

http://lieberman.senate.gov/index.cfm/news-events/news/2010/9/dodd-lieberman-announce-major-defense-investments-for-connecticut

AT&T launching first LTE network next year:
http://www.techeye.net/business/att-will-launch-its-first-lte-network-in-summer-of-2011

SCON (1.69) Nice breakout today on 10X avg. volume. Big gap to fill from here!

SCON (1.63) Anybody watching this one? Volume picking up again.

SCON (1.63) Nice volume too! Almost 2X avg. already. Huge gap to fill now.

SCON - Broke 1.60 resistance. Nice run in store now.

HERO - Matt great set of charts! If selling pressue continues what would be good entry price to look for in your opinion?

CXM - Closing in on 2mil shares traded. Unreal! Will be interesting to see where this closes.

hopefully we can punch through that .58. looking very good here!

CXM - bullish article today on Small Cap Network website:
http://www.smallcapnetwork.com/Your-Best-Bullish-Bets-Right-Now-Looks-at-CXM-SPEX-and-LQMT/s/article/view/p/mid/2/id/308/

CXM (.52)- Joining you! Found this on the Lion:

Excellagen Wound Care Management Platform:
Initial product has pending FDA 510(k)
submission for marketing and sales clearance which is targeted for 2010 market launch ¦ Other product line extensions currently under development

1) MedPodium In-House Brand Initiative:
Planning to launch initial seven products in Oct/2010 ¦Product line extensions planned for 2011 and 2012 ¦ Full product line is planned to cover Medicinals, Neurologics, Metabolics and Aesthetics ¦ New weight loss product launch pending

2) Acquisition Search: Challenging economic environment continues to generate a steady
stream of deal flow ¦CXM remains highly selective and has evaluated over 20 opportunities
in the past six months

3) Key Investor Metrics:
No outstanding debt, substantial trading liquidity, continuing news flow expected ¦ Current capital structure provides for significant economic upside potential as CXM executes business strategy

CXM (.52)-breaking out above 200dma with nice volume surge!

LTS - Closed at 1.08 HOD. Sitting right at 200MA

why this big drop???? don't see any news that would cause this.

Good sign. Your right, tomorrow could be big day. Chart looks great!

MDW - Lots of recent insider purchases. Many at higher prices.

MDW - Taking off? I don't see it. Just dropped .02 & Not even close to avg daily volume.

Glen, I know tough question, but how low do you think this can go?I hate trying to catch a falling knife. Seems CNAM has broken through all support levels now. Looks like market could easily test 9500 soon. You think CNAM could see $2.50 or lower? Thanks.

AFFY is a girl??? Explains why I lost $$$ on that one.

GSAT - Opened @ 1.75. Trade @ 1.79 on almost no shares. Weird. Yes, Has been consolidating nicely. They will announce addition to Russell Index Friday. Correct?

The volume is crazy. I agree with Langy, who would be selling here???

AFFY - Was the news that BAD??? I didn't think so.

THE BIG PICTURE: Hematide is the company's lead drug candidate and if approved, it would compete in an already competitive market. That market includes Amgen Inc.'s Aranesp.

THE ANALYSIS: Leerink Swann Research analyst Dr. Joshua Schimmer said Hematide's regulatory and commercial prospects are "clouded" by some of the results in the latest studies. In a note to Affymax investors on Monday, he cited some mixed results on effectiveness, though the study met its key goals in that area. But, the safety results could be problematic, he said.

"Nephrologists with whom we have spoken prefer to gain experience with Hematide in the predialysis setting prior to switching their dialysis units over to Hematide, so these results present an incremental commercial hurdle and obvious regulatory concern," he said.

GL - Langy, hopefully near bottom now!

AFFY - Still sinking. Not sure where the bottom is with this one.

AFFY - This is getting hard to watch. No bouncy with affy. No doubt it will recover some, but may take a few days IMO.

AFFY - Crazy now. Doesn't know which way to go.

AFFY - Thought would be back over $9 by now. looks like it found support though. Should only go higher from here.

HOD last friday was .8399. My prediction turned out to be good although to the lower end of the range I posted. I think everyone made out well with this one. GLTA

NMTI has a float of only 15.32M of which 59% of shares are held by institutions, mutual funds, and insiders. That leaves approx. 6M shares for retail. http://finance.yahoo.com/q/mh?s=NMTI+Major+Holders

The news posted today was not all that bad IMO and NMTI has many other products in the pipeline along with ongoing clinical studies. I can see this jumping back up rather quickly from where it closed today. The AH trading being an indication with over 1M shares traded and a 20% recovery.

I think just buying pressure tomorrow from day/swing traders could move this to the .80-1.00 easily.

Hold even longer and you can reap the rewards of some positive PR's that will be made when NMTI's RT2 Delivery System is launched throughout Europe in the next few months.

NMTI has a float of only 15.32M of which 59% of shares are held by institutions, mutual funds, and insiders. That leaves approx. 6M shares for retail. http://finance.yahoo.com/q/mh?s=NMTI+Major+Holders

The news posted today was not all that bad IMO and NMTI has many other products in the pipeline along with ongoing clinical studies. I can see this jumping back up rather quickly from where it closed today. The AH trading being an indication with over 1M shares traded and a 20% recovery.

I think just buying pressure tomorrow from day/swing traders could move this to the .80-1.00 easily.

Hold even longer and you can reap the rewards of some positive PR's that will be made when NMTI's RT2 Delivery System is launched throughout Europe in the next few months.

NMTI - Last trades @ .66 AH. Looking good for tomorrow.
http://www.nasdaq.com/aspxcontent/ExtendedTradingTrades.aspx?selected=nmti&mkttype=after

NMTI - Pipeline & Clinical studies:
http://www.snl.com/IRWebLinkX/GenPage.aspx?IID=4148066&GKP=202520
Company has many other things going on. This could bounce hard tomorrow IMO

NMTI - $2.82 HOD down to .52. Overdone to say the least! Should bounce nicely tomorrow.

LOL, yeah it is! 'bout time.